Top 10 Stocks with the Highest Growth in Early 2025

Investors often look back on a given year to identify the top performing stocks and examine what fueled their remarkable gains. The year 2025 saw a dynamic market shaped by technological breakthroughs, shifting consumer preferences, and broader global economic trends. From streaming services and clean energy innovations to cutting-edge medical research and fintech breakthroughs, multiple companies stood out for their stock surges. Below is a rundown of 10 leading companies that recorded the highest year-to-date returns as of January 31, 2025. Each listing highlights the percentage growth, a rough price move, and a brief explanation of the company’s core business and factors contributing to its remarkable rise in stock performance.

10. Inari Medical Inc. (NARI)

• Year-to-Date Return: 56.0%

Inari Medical focuses on developing medical devices aimed at treating venous diseases. The company’s strong performance in 2025 is partly driven by successful clinical trials showcasing the effectiveness of its new interventions for conditions like deep vein thrombosis. With robust results and growing acceptance among physicians, Inari attracted significant investor interest. Its emphasis on improving patient outcomes resonated in a healthcare sector eager for innovative solutions. The confluence of a supportive regulatory environment and promising sales figures contributed to the upward trend in its stock price.

9. Exodus Movement Inc. (EXOD)

• Year-to-Date Return: 62.6%

Exodus Movement has carved a niche by offering cryptocurrency wallet solutions that prioritize user-friendliness and security. As digital assets gained renewed traction in 2025, many investors saw Exodus’s platform as a gateway for mainstream users entering the crypto realm. The company’s approachable interface appealed to a broad demographic, while frequent updates and enhanced security measures built consumer trust. Heightened interest in decentralized finance (DeFi) and digital payments helped propel the stock as more people sought reliable ways to store and manage cryptocurrencies.

8. Grail Inc. (GRAL)

• Year-to-Date Return: 69.6%

Grail concentrates on early cancer detection using innovative blood test technologies. The ongoing development of its multi-cancer early detection tests gained traction when preliminary trial data suggested increased accuracy for detecting various types of cancer at earlier stages. This breakthrough captured the attention of healthcare professionals, insurers, and biotech investors focused on public health innovations. Partnerships with leading hospitals and a spike in global demand for preventative medical solutions also played a role, sending Grail’s share price higher throughout 2025.

7. Tempus AI Inc. (TEM)

• Year-to-Date Return: 69.9%

Tempus AI specializes in artificial intelligence solutions applied across multiple sectors, including finance, healthcare, and logistics. Its success in 2025 resulted from major contracts secured in the insurance and pharmaceutical realms, demonstrating real-world applications of machine learning algorithms. Positive analyst coverage highlighted its accelerating revenue growth and expansion into new verticals. Investors appreciated Tempus AI’s focus on practical use cases rather than theoretical research, leading to steady stock gains as adoption of AI-driven tools continued to climb in the global marketplace.

6. Agilon Health Inc. (AGL)

• Year-to-Date Return: 75.7%

Agilon Health partners with primary care physicians to revamp healthcare delivery for senior patients. By modernizing clinical systems and integrating data analytics, Agilon reduces administrative burdens and improves patient outcomes. As more healthcare providers faced the challenge of an aging population in 2025, Agilon’s model attracted broad support. The positive impact on patient satisfaction and cost savings fueled optimism around the firm’s business model. When the company reported higher-than-expected quarterly revenues and announced new partnerships, the stock surged in line with heightened confidence in value-based care strategies.

5. OppFi Inc. (OPFI)

• Year-to-Date Return: 78.9%

OppFi is a financial technology (fintech) platform offering accessible lending products. Its solutions help consumers who might be overlooked by traditional banks, bridging an important gap in the credit market. In 2025, OppFi’s expanded partnerships with e-commerce and payment platforms improved visibility, while strong financial results demonstrated consistent loan growth and lower-than-expected default rates. The fintech sector’s resilience amid ongoing shifts in consumer banking preferences further ignited investor interest in OppFi’s stock, making it a favorite among those seeking high-growth fintech plays.

4. H&E Equipment Services Inc. (HEES)

• Year-to-Date Return: 81.1%

H&E Equipment Services operates in the heavy machinery domain, offering rental and sales services tailored to construction and industrial clients. With 2025 seeing substantial public and private investment in infrastructure—ranging from highways and bridges to commercial real estate—demand for construction equipment spiked considerably. H&E’s strategic expansion into new regions and consistent customer satisfaction boosted revenues. Its ability to manage supply chain complexities effectively further convinced investors that the company was well-positioned to ride the wave of infrastructure spending.

3. Akero Therapeutics Inc. (AKRO)

• Year-to-Date Return: 94.3%

Akero Therapeutics focuses on developing treatments for non-alcoholic steatohepatitis (NASH), a liver condition affecting a growing number of people worldwide. Encouraging trial data and positive feedback from regulatory bodies played a crucial role in Akero’s dramatic stock appreciation. Analysts pointed to the untapped potential of the NASH market, with few existing treatments available. As a result, investors recognized the commercial viability of Akero’s pipeline. The biotech sector as a whole enjoyed renewed interest in 2025, but Akero’s near-term pipeline milestones stood out, consolidating its stock surge.

2. Oklo Inc. (OKLO)

• Year-to-Date Return: 96.0%

Oklo specializes in advanced nuclear reactor technology, pursuing safer and more efficient ways to generate clean energy. In 2025, policy shifts toward renewable and sustainable energy sources supported Oklo’s initiatives. Innovations that lowered the cost and environmental impact of nuclear power, combined with notable regulatory approvals, attracted the attention of climate-focused investors. Partnerships with major utilities reinforced investor trust, while the global emphasis on decarbonization validated Oklo’s long-term market prospects. This convergence of policy, technology, and environmental consciousness helped drive the stock’s strong climb.

1. FuboTV Inc. (FUBO)

• Year-to-Date Return: 220.6%

FuboTV leads the year’s list of companies with highest stock surges thanks to its sports-focused streaming service. The platform streams live sports, news, and entertainment, catering to cord-cutters who still crave real-time access to events. In 2025, FuboTV accelerated user growth, expanding its reach into sports betting—a move that strengthened its revenue base and synergy between streaming and interactive sports experiences. Analysts noted that its strategic partnerships with leagues and rapid adaptation to consumer streaming habits propelled FuboTV’s shares. The bold foray into online betting set it apart from rival streaming services, capturing a lucrative market segment and catapulting its stock to the top spot.

Very Volatile Start To The Year

Each of these 10 companies—ranging from fintech to biotech and digital advertising—offers a unique perspective on the markets shaping the future. Some leveraged cutting-edge technologies like AI and advanced medical diagnostics; others capitalized on macro trends, such as rising infrastructure spending or the shift to streaming entertainment. In all cases, a combination of innovation, strategic partnerships, and positive market sentiment contributed to remarkable share price growth.

While these stocks stood out for their percentage growth and year-to-year performance, they also highlight broader economic and cultural trends. From an investor standpoint, these success stories underscore the importance of anticipating shifts in consumer behavior, regulatory landscapes, and technological advancements. Whether readers are seasoned investors or simply market observers, the 2025 surge of these companies offers lessons on how adaptability and forward-thinking can generate high returns—even in fiercely competitive sectors.

‍